Recent Developments in Cardiology Procedures for Adult Congenital Heart Disease: The Anesthesiologist's Perspective

Dylan T Finnerty1, Michael Griffin1

  • 1Division of Anesthesiology, Mater Misericordiae University Hospital, Dublin, Ireland; School of Medicine, University College Dublin, Dublin, Ireland.

Insights

Adult congenital heart disease (ACHD) patients require specialized care, often in cardiac catheterization labs. Anesthesiologists must manage unique challenges, including altered anatomy and potential airway difficulties, for improved patient outcomes.

Area of Science:

  • Cardiology
  • Anesthesiology
  • Adult Congenital Heart Disease

Background:

  • Improvements in surgical techniques and perioperative care have increased survival rates for children with congenital heart disease (CHD).
  • Adult congenital heart disease (ACHD) patients frequently require reinterventions and specialized management throughout their lives.
  • Surgical correction of conditions like tetralogy of Fallot can lead to long-term complications such as pulmonary valve dysfunction.

Purpose of the Study:

  • To highlight the evolving management strategies for adult congenital heart disease (ACHD) patients.
  • To emphasize the role of cardiac catheterization and electrophysiology laboratories in managing ACHD patients.
  • To inform anesthesiologists about the specific challenges and considerations when providing care to ACHD patients outside the traditional operating room setting.

Main Methods:

  • Review of current interventional cardiology and electrophysiology procedures applicable to ACHD.
  • Discussion of percutaneous interventions, such as valve replacement, as alternatives to resternotomy.
  • Analysis of anesthetic considerations for ACHD patients, including airway management and potential complications like coronary artery compression.

Main Results:

  • Percutaneous approaches offer less invasive options for interventions like pulmonary valve replacement.
  • ACHD patients often require pacemaker/implantable cardioverter-defibrillator (ICD) insertion or ablation, presenting unique anatomical challenges.
  • Altered cardiac anatomy and associated orofacial abnormalities in ACHD patients can lead to difficult airway scenarios.

Conclusions:

  • ACHD patients can be effectively managed with modern interventional techniques in specialized labs.
  • Anesthesiologists must possess comprehensive knowledge of ACHD anatomy and planned procedures to ensure safe anesthesia outside the operating room.
  • Careful airway management planning, considering factors like transesophageal echocardiography, is crucial for ACHD patients undergoing catheterization procedures.

Related Concept Videos

Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
725
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
190
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
173
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
417
Cardiac Catheterization II: Right Heart Catheterization01:21

Cardiac Catheterization II: Right Heart Catheterization

Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
499
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
293